SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
LATE-BREAKING CLINICAL STUDIES ON COVID-19 AND MPOX
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
ENSITRELVIR FOR MILD-TO-MODERATE COVID-19: PHASE 3 PART OF PHASE 2/3 STUDY (ABSTRACT
166)
Takeki Uehara
Shionogi & Co., Ltd., Osaka, Japan
EFFECT OF EARLY TREATMENT WITH PEGYLATED INTERFERON LAMBDA FOR COVID-19 (ABSTRACT
167)
Jeffrey S. Glenn
Stanford University School of Medicine, Stanford, CA, United States
CHARACTERIZATION OF SINGLE VERSUS DUAL ACTIVE mAB AGAINST SARS-CoV-2 (ABSTRACT
168)
Manish C. Choudhary
Brigham and Women's Hospital, Cambridge, MA, United States
SAFETY AND EFFICACY OF INHALED INTERFERON-ß1A (SNG001) IN OUTPATIENTS WITH COVID-19 (ABSTRACT
169)
William Fischer
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
QUESTIONS AND ANSWERS (Part 1)
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Anne F. Luetkemeyer
University of California San Francisco, San Francisco, CA, United States
METFORMIN REDUCED SARS-CoV-2 VIRAL LOAD IN A PHASE 3 RANDOMIZED CLINICAL TRIAL (ABSTRACT
170)
Carolyn Bramante
University of Minnesota, Minneapolis, MN, United States
SYMPTOM AND VIRAL REBOUND IN UNTREATED COVID-19 INFECTION (ABSTRACT
171)
Rinki Deo
Brigham and Women's Hospital, Cambridge, MA, United States
COVID-19 HOSPITALIZATION RISK AFTER SARS-CoV-2 VACCINATION AND OUTPATIENT TREATMENT (ABSTRACT
172)
Heather Henderson
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
MPOX IN PEOPLE LIVING WITH HIV AND CD4 COUNTS < 350 CELLS/MM3: A GLOBAL CASE SERIES (ABSTRACT
173)
Chloe Orkin
Queen Mary University of London, London, United Kingdom
QUESTIONS AND ANSWERS (Part 2)
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Anne F. Luetkemeyer
University of California San Francisco, San Francisco, CA, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
